Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial.

Aladdin, H; Ullum, H; Dam Nielsen, S; Espersen, C; Mathiesen, L; Katzenstein, T L; Gerstoft, J; Skinhoj, P; Pedersen, B K

Aladdin, H; Ullum, H; Dam Nielsen, S; Espersen, C; Mathiesen, L; Katzenstein, T L; Gerstoft, J; Skinhoj, P; Pedersen, B K.

Affiliation

Aladdin H; Department of Infectious Diseases, Rigshospitalet, Tagensvej 20, 2200 Copenhagen N, Denmark. Infdisha@rh.dk

J Infect Dis ; 181(3): 1148-52, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10720544

Subject(s)

CD4 Lymphocyte Count/drug effects; Granulocyte Colony-Stimulating Factor/pharmacology; HIV Infections/drug therapy; Adult; Aged; Female; HIV Infections/immunology; Humans; Interleukin-2/biosynthesis; Killer Cells, Natural/drug effects; Killer Cells, Natural/immunology; Lymphocyte Activation/drug effects; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Granulocyte Colony-Stimulating Factor / CD4 Lymphocyte Count Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Infect Dis Year: 2000 Document type: Article Affiliation country: Denmark Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links